Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 949-316-9 | CAS number: 1965233-46-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- starting dose was 200 mg/kg
- Principles of method if other than guideline:
- References for test guidelines given in the study report:
EEC Directive 92/69, Publication No. L383A, B.1: Acute Toxicity-oral, December 29, 1992;
Acute toxic class method, A national validation study of the ATC Method - an alternative to the LD50 test, Arch. Toxicol. 66: 455-470, 1992 - GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- 1-(4-chlorophenyl)pyrazol-3-ol
- EC Number:
- 616-307-3
- Cas Number:
- 76205-19-1
- Molecular formula:
- C9 H7 Cl N2 O
- IUPAC Name:
- 1-(4-chlorophenyl)pyrazol-3-ol
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): pyrazolon
- Physical state: crystalline powder, light-beige
- Analytical purity/Content: 100.5 g/ 100 g (H-NMR and IR spectroscopy)
- Lot/batch No.: 27967/95
- Storage condition of test material: room temperature, exclusion of light
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. K. Thomae GmbH, Biberach, Federal Republic of Germany
- Age at study initiation: young adults
- Weight at study initiation: animals of comparable weight; 150-300g (+/- 20% of the mean weight)
- Fasting period before study: at least 16 hours before administration
- Housing: single housing, stainless steel wire mesh cages
- Diet (e.g. ad libitum): ad libitum (Kliba labor diet 343, assayed for chemical and microbiological contaminants)
- Water (e.g. ad libitum): ad libitum (tap water, regularly assayed for chemical contaminants)
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C (no deviations from these ranges which influenced the results of the study)
- Humidity (%): 30 - 70% (no deviations from these ranges which influenced the results of the study)
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- VEHICLE
(cleaned natriumcarboxymethylcellulose in aqua bidest.)
- Concentration in vehicle: 2 g/100 ml and 20 g/100 ml
- Amount of vehicle (if gavage): 10 ml/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: based on the physical and chemical characteristics of the test substance - Doses:
- 200 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
clinical signs and symptoms: several times on the day of administration, at least once each workday;
mortality: twice each workday and once on Saturdays and Sundays;
body weights: d0 (shortly before application), weekly thereafter and at the end of the study (before fasting period)
- Necropsy of survivors performed: yes (withdrawl of food at least 16 hours before killing with CO2)
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortalities occured
- Clinical signs:
- other: 200 mg/kg: no symptoms observed in males and females 2000 mg/kg: all males showed an impaired or poor general state, dyspnoea, staggering and piloerection, 2/3 males showed apathy; in female animals no abnormalities were observed
- Gross pathology:
- No findings
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.